FDA Announces New Label for Ortho Evra
Press Release from the US FDA announcing the new label for Ortho Evra to give warning about the women’s exposure to greater estrogen levels.
FDA Responses to the Questions about the Change of Label
FDA answers the inquiries regarding the change in the label of Ortho Evra giving its users warnings about the potential exposure to higher level of estrogen.
Ortho Evra Drug Information
A detailed information regarding the side effects and adverse reactions associated with the use of Ortho Evra and the prescribing information; from the Ortho-McNeil Pharmaceutical Inc.
Public Citizen Alerts Women: Do Not Use Ortho Evra
The statement of the Director of Public citizen Health Research Group discouraging women from using Ortho Evra.
Ortho Evra Introduced into the Market as Posing the Same Risks as the Pill
Read the reports regarding Ortho Evra in comparison with the traditional birth control pills, and claiming that the risks of these birth control patches are similar with the oral contraceptives.
CBS/Associated Press Report about the Dangers Posed by Ortho Evra
An in-depth report in response to the announcement of the US FDA that Ortho Evra users are subjected to higher estrogen levels and other adverse side effects.